GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
A Phase I Rheumatoid Arthritis Study in Healthy Volunteers
- First Posted Date
- 2007-10-05
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 45
- Registration Number
- NCT00539760
- Locations
- 🇺🇸
GSK Investigational Site, Baltimore, Maryland, United States
Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus
- First Posted Date
- 2007-10-05
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 57
- Registration Number
- NCT00539994
- Locations
- 🇺🇸
GSK Investigational Site, Tacoma, Washington, United States
A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers
- Conditions
- Healthy Subjects
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 12
- Registration Number
- NCT00539136
- Locations
- 🇺🇸
GSK Investigational Site, Lexington, Kentucky, United States
GSK706769 A First Time in Human Study For Males and Females
- Conditions
- Healthy Subjects
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 34
- Registration Number
- NCT00539201
- Locations
- 🇺🇸
GSK Investigational Site, Madison, Wisconsin, United States
Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS
- Conditions
- Rhinitis, Allergic, Perennial
- Interventions
- Drug: FPNSDrug: placebo FPNSDrug: FFNSDrug: placebo FFNS
- First Posted Date
- 2007-10-03
- Last Posted Date
- 2016-12-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 377
- Registration Number
- NCT00539006
- Locations
- 🇺🇸
GSK Investigational Site, South Burlington, Vermont, United States
Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects
- Conditions
- Asthma
- Interventions
- Drug: GW685698X & GW642444M
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2017-08-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 16
- Registration Number
- NCT00538057
- Locations
- 🇦🇺
GSK Investigational Site, Randwick, Sydney, New South Wales, Australia
Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
- Conditions
- Influenza
- Interventions
- Biological: GSK Bio's Influenza Vaccine GSK576389ABiological: Fluarix™
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 133
- Registration Number
- NCT00538213
- Locations
- 🇧🇪
GSK Investigational Site, Gent, Belgium
Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
- Conditions
- Influenza
- Interventions
- Biological: GSK Biologicals' influenza vaccine GSK576389ABiological: Fluarix™
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 68
- Registration Number
- NCT00538473
- Locations
- 🇧🇪
GSK Investigational Site, Gent, Belgium
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
- Conditions
- Prostatic Hyperplasia
- Interventions
- Drug: Treatment sequence CDrug: Treatment sequence ADrug: Treatment sequence B
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 81
- Registration Number
- NCT00537654
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 34
- Registration Number
- NCT00537719
- Locations
- 🇺🇸
GSK Investigational Site, Lexington, Kentucky, United States